Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2026 Earnings Call Transcript May 14, 2026Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.33, expectations were $-1.885.
